Current News Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associat... Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associat... 2023-04-03 04:00:00 Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associat... Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associat... 2023-04-03 04:00:00 Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination 2023-04-03 04:00:00 Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management 2023-04-03 04:00:00 Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals 2023-04-03 04:00:00 Pagination First page « First Previous page ‹ Previous … Page 10091 Page 10092 Page 10093 Page 10094 Current page 10095 Page 10096 Page 10097 Page 10098 Page 10099 … Next page Next › Last page Last »
